Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast can...
Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
About this item
Full title
Author / Creator
Publisher
United States: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
The selection of chemotherapeutic regimens is challenging for metastatic breast cancer (MBC) patients whose diseases have failed to respond to anthracyline and taxane. Capecitabine has advantages of oral administration and favorable toxicity profiles. This study was conducted to evaluate the efficacy of capecitabine and to identify the subgroup of...
Alternative Titles
Full title
Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_875572221
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_875572221
Other Identifiers
ISSN
1357-0560
E-ISSN
1357-0560,1559-131X
DOI
10.1385/MO:21:3:223
